Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
F-star Therapeutics, Inc. (SBPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| Kayitalire Louis (CHIEF MEDICAL OFFICER) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 29,236 shares
@ $7.12, valued at
$208.2k
Disposed/sold 25,019 shares
@ $7.12, valued at
$178.1k
Disposed/sold 27,289 options to buy
@ $16.62, valued at
$453.5k
Disposed/sold 12,880 options to buy
@ $7.24, valued at
$93.3k
Disposed/sold 53,634 options to buy
@ $4.77, valued at
$255.8k
Disposed/sold 35,719 options to buy
@ $3.55, valued at
$126.8k
|
|
| 03/09/2023 |
4
| Forster Eliot (PRESIDENT AND CEO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 347,578 shares
@ $7.12, valued at
$2.5M
Disposed/sold 73,959 shares
@ $7.12, valued at
$526.6k
Disposed/sold 127,924 options to buy
@ $7.24, valued at
$926.2k
Disposed/sold 165,028 options to buy
@ $4.77, valued at
$787.2k
Disposed/sold 126,909 options to buy
@ $3.55, valued at
$450.5k
|
|
| 03/09/2023 |
4
| Klein Pamela M. (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 15,000 options to buy
@ $4.62, valued at
$69.3k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 03/09/2023 |
4
| DEPTULA-HICKS DARLENE M (See Remarks) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 30,898 shares
@ $7.12, valued at
$220k
Disposed/sold 25,539 shares
@ $7.12, valued at
$181.8k
Disposed/sold 28,426 options to buy
@ $16.62, valued at
$472.4k
Disposed/sold 25,894 options to buy
@ $7.34, valued at
$190.1k
Disposed/sold 59,823 options to buy
@ $4.77, valued at
$285.4k
Disposed/sold 24,902 options to buy
@ $3.55, valued at
$88.4k
|
|
| 03/09/2023 |
4
| Brady Todd C (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 15,004 shares
@ $7.12, valued at
$106.8k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 11,000 options to buy
@ $9.05, valued at
$99.6k
Disposed of 10,964 warrants
@ $10.79, valued at
$118.3k
Disposed of 5,500 options to buy
@ $14.27, valued at
$78.5k
Disposed of 5,500 options to buy
@ $13.99, valued at
$76.9k
Disposed of 7,500 options to buy
@ $4.62, valued at
$34.7k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 03/09/2023 |
4
| Brewis Neil (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 105,088 shares
@ $7.12, valued at
$748.2k
Disposed/sold 9,375 shares
@ $7.12, valued at
$66.8k
Disposed/sold 22,561 options to buy
@ $7.24, valued at
$163.3k
Disposed/sold 74,263 options to buy
@ $4.77, valued at
$354.2k
Disposed/sold 132,469 options to buy
@ $3.55, valued at
$470.3k
|
|
| 03/09/2023 |
4
| Race Geoffrey (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,937 shares
@ $7.12, valued at
$28k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
|
|
| 03/09/2023 |
4
| Bermingham Nessan (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 97,547 shares
@ $7.12, valued at
$694.5k
Disposed/sold 6,328 shares
@ $7.12, valued at
$45.1k
Disposed/sold 34,111 options to buy
@ $16.62, valued at
$566.9k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
|
|
| 03/09/2023 |
4
| Benz Edward JR (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Disposed/sold 4,385 shares
@ $7.12, valued at
$31.2k
Disposed/sold 3,937 options to buy
@ $14.31, valued at
$56.3k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
|
|
| 03/09/2023 |
4
| Arkowitz David (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 8,386 shares
@ $7.12, valued at
$59.7k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
Disposed/sold 20,000 options to buy
@ $3.41, valued at
$68.2k
Disposed of 10,000 options to buy
@ $9.28, valued at
$92.8k
Disposed of 5,500 options to buy
@ $9.05, valued at
$49.8k
Disposed of 4,386 warrants
@ $10.79, valued at
$47.3k
Disposed of 5,500 options to buy
@ $14.27, valued at
$78.5k
Disposed of 5,500 options to buy
@ $13.99, valued at
$76.9k
Disposed of 7,500 options to buy
@ $4.62, valued at
$34.7k
Disposed of 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 01/09/2023 |
4
| Race Geoffrey (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Exercised 3,937 shares
@ $0.11, valued at
$433.1
Exercised 3,937 options to buy
@ $0 |
|
| 08/02/2022 |
4
| Forster Eliot (President and CEO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Exercised 260,977 shares
@ $0.11, valued at
$28.7k
Exercised 32,602 options to buy
@ $0
Exercised 228,375 options to buy
@ $0 |
|
| 08/02/2022 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Exercised 76,619 shares
@ $0.11, valued at
$8.4k
Exercised 6,307 options to buy
@ $0
Exercised 70,312 options to buy
@ $0 |
|
| 06/22/2022 |
4
| Brady Todd C (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $3.41, valued at
$68.2k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Klein Pamela M. (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $3.41, valued at
$68.2k
|
|
| 06/22/2022 |
4
| Bermingham Nessan (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $3.41, valued at
$68.2k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Forster Eliot (President and CEO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 126,909 options to buy
@ $3.55, valued at
$450.5k
|
|
| 04/04/2022 |
4
| DEPTULA-HICKS DARLENE M (Treasurer and CFO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 24,902 options to buy
@ $3.55, valued at
$88.4k
|
|
| 04/04/2022 |
4
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 35,719 options to buy
@ $3.55, valued at
$126.8k
|
|
| 04/04/2022 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 132,469 options to buy
@ $3.55, valued at
$470.3k
|
|
| 01/11/2022 |
4
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 53,634 options to buy
@ $4.77, valued at
$255.8k
|
|
| 01/11/2022 |
4
| DEPTULA-HICKS DARLENE M (Treasurer and CFO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 59,823 options to buy
@ $4.77, valued at
$285.4k
|
|
| 01/11/2022 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 74,263 options to buy
@ $4.77, valued at
$354.2k
|
|
| 01/11/2022 |
4
| Forster Eliot (President and CEO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 165,028 options to buy
@ $4.77, valued at
$787.2k
|
|
| 11/04/2021 |
4
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Sold 39 shares
@ $6.81, valued at
$265.6
Sold 25 shares
@ $6.85, valued at
$171.3 |
|
| 10/06/2021 |
4
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Sold 64 shares
@ $7.2256, valued at
$462.4 |
|
| 08/24/2021 |
4/A
| Bermingham Nessan (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 16,875 shares
@ $0 |
|
| 08/24/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/24/2021 |
4/A
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 26,437 shares
@ $0 |
|
| 07/07/2021 |
4
| Kayitalire Louis (Chief Medical Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Sold 1,054 shares
@ $8.43, valued at
$8.9k
|
|
| 06/07/2021 |
4
| Krol Patrick Johan Hendrik (Director) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $6.88, valued at
$137.6k
|
|
|
|
|